Power provides a patient-friendly platform aimed at improving access to clinical trial studies. Its proprietary AI translates medical jargon from trial descriptions into clear, accurate language and links patients with researchers to assess eligibility. The database already covers more than 30,000 clinical trials, 100,000 researchers and 10,000 medical conditions. Management expects the platform to serve over 500,000 patients in 2022. The company’s near-term focus is to broaden patient access and increase diversity within trials, goals that will be supported by its recent capital infusion. No revenue figures were disclosed in the article, but the scale of user engagement indicates early traction for the service.

Total raised

$19M

Funding rounds

2

Latest round

Series A

Latest activity

Feb 2024